title: REPLY: Treatment with oxLDL antibody reduces cathepsin S expression in atherosclerosis via down-regulating ADAR1-mediated RNA editing.
authors.affiliation: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: cbpoulsen@clin.au.dk.
authors.forename: Christian Bo
authors.initials: CB
authors.lastname: Poulsen
authors.affiliation: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
authors.forename: Ahmed Ludvigsen
authors.initials: AL
authors.lastname: Al-Mashhadi
authors.affiliation: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
authors.forename: Jacob Fog
authors.initials: JF
authors.lastname: Bentzon
authors.affiliation: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
authors.forename: Erling
authors.initials: E
authors.lastname: Falk
mesh_terms: D000243:Adenosine Deaminase / Q000378:metabolism*; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D002403:Cathepsins / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000378:metabolism / Q000628:therapy; D015536:Down-Regulation; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000037:antagonists & inhibitors / Q000276:immunology; D017393:RNA Editing / Q000187:drug effects; D016601:RNA-Binding Proteins / Q000378:metabolism*; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D008077:Lipoproteins, LDL; D016601:RNA-Binding Proteins; D011994:Recombinant Proteins; C099252:oxidized low density lipoprotein; D002403:Cathepsins; C028217:cathepsin S; C000595356:ADAR protein, human; D000243:Adenosine Deaminase